Published in Eur J Clin Pharmacol on January 01, 1983
Are circulating metabolites important in drug-drug interactions?: Quantitative analysis of risk prediction and inhibitory potency. Clin Pharmacol Ther (2010) 0.95
Electrical changes produced by injury to the rat myocardium in vitro and the protective effects of certain antiarrhythmic drugs. Br J Pharmacol (1987) 0.91
Plasma levels and pharmacokinetics of sulphinpyrazone in renal impairment during chronic treatment: a case report. Br J Clin Pharmacol (1984) 0.75
Effect of a selective CYP2C9 inhibitor on the pharmacokinetics of nateglinide in healthy subjects. Eur J Clin Pharmacol (2004) 0.75
Estimate of human gene number provided by genome-wide analysis using Tetraodon nigroviridis DNA sequence. Nat Genet (2000) 14.51
Haplotype sharing analysis using mantel statistics. Hum Hered (2005) 6.76
Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis. N Engl J Med (1999) 5.02
Alternative polyadenylation events contribute to the induction of NF-ATc in effector T cells. Immunity (1999) 3.69
Small-bowel diverticulosis: perceptions and reality. J Am Coll Surg (1997) 3.09
Urinary prostaglandins. Identification and origin. J Clin Invest (1975) 3.07
Non-random radial higher-order chromatin arrangements in nuclei of diploid human cells. Chromosome Res (2001) 2.89
The Ets-1 transcription factor is required for the development of natural killer cells in mice. Immunity (1998) 2.68
Effects of caffeine on plasma renin activity, catecholamines and blood pressure. N Engl J Med (1978) 2.50
Therapeutic efficacy of sulfasalazine and its metabolites in patients with ulcerative colitis and Crohn's disease. N Engl J Med (1980) 2.39
Hearing preservation in acoustic neurinoma surgery. J Neurosurg (1992) 2.33
Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease. Circulation (1997) 2.20
Oscillatory synchrony between human extrastriate areas during visual short-term memory maintenance. J Neurosci (2001) 2.08
Neuromonitoring during surgery. Report of an IFCN Committee. Electroencephalogr Clin Neurophysiol (1993) 1.93
Laparoscopic nephrectomy: the experience of the laparoscopy working group of the German Urologic Association. J Urol (1998) 1.93
Shanxi Province Cervical Cancer Screening Study: a cross-sectional comparative trial of multiple techniques to detect cervical neoplasia. Gynecol Oncol (2001) 1.93
Cloning of murine Stat6 and human Stat6, Stat proteins that are tyrosine phosphorylated in responses to IL-4 and IL-3 but are not required for mitogenesis. Mol Cell Biol (1995) 1.85
Intravascular ultrasound assessment of lumen size and wall morphology in normal subjects and patients with coronary artery disease. Circulation (1991) 1.83
Selective attenuation of endothelium-mediated vasodilation in atherosclerotic human coronary arteries. Circ Res (1988) 1.77
Long-term outcomes of chronic minimally conscious and vegetative states. Neurology (2010) 1.76
Radioiodine therapy of Graves' hyperthyroidism: standard vs. calculated 131iodine activity. Results from a prospective, randomized, multicentre study. Eur J Clin Invest (1995) 1.73
Defective thymocyte proliferation and IL-2 production in transgenic mice expressing a dominant-negative form of CREB. Nature (1996) 1.65
Long-term efficacy of gamma knife radiosurgery in mesial temporal lobe epilepsy. Neurology (2008) 1.64
Suppression of plasma renin activity by indomethacin in man. Circ Res (1976) 1.62
Searching for the exercise factor: is IL-6 a candidate? J Muscle Res Cell Motil (2003) 1.60
Characterization and repeat analysis of the compact genome of the freshwater pufferfish Tetraodon nigroviridis. Genome Res (2000) 1.57
Bartter's syndrome: a disorder characterized by high urinary prostaglandins and a dependence of hyperreninemia on prostaglandin synthesis. Am J Med (1976) 1.55
Mechanism of antihypertensive action of ketanserin in man. Br Med J (Clin Res Ed) (1983) 1.47
Abnormal pulmonary artery pressure response in asymptomatic carriers of primary pulmonary hypertension gene. Circulation (2000) 1.46
The metabolic role of IL-6 produced during exercise: is IL-6 an exercise factor? Proc Nutr Soc (2004) 1.45
A selective imaging of tinnitus. Neuroreport (1999) 1.44
Autonomic nervous system and neuroendocrine changes in patients with idiopathic trigeminal neuralgia. Cephalalgia (1996) 1.44
Lateralization in autonomic dysfunction in ischemic stroke involving the insular cortex. Neuroreport (2004) 1.44
[Diagnosis of vitamin B12 deficiency revised]. Ned Tijdschr Geneeskd (2005) 1.43
[Fifteen practical questions concerning gestational diabetes]. Gynecol Obstet Fertil (2007) 1.41
Treatment of American cutaneous leishmaniasis with miltefosine, an oral agent. Clin Infect Dis (2001) 1.41
L-arginine-induced vasodilation in healthy humans: pharmacokinetic-pharmacodynamic relationship. Br J Clin Pharmacol (1998) 1.39
[Aspirin--yes, but 30 mg??]. Z Kardiol (1995) 1.39
[Chemoprevention of prostate cancer - a plea]. Aktuelle Urol (2012) 1.39
[What is the recurrence rate for Basedow's disease treated with thyrostatic agents. Answers from a prospective study]. Schweiz Med Wochenschr (1990) 1.39
[Constipation after tilidine/naloxone and tramadol in comparison to codeine. A dose response study in human volunteers]. Schmerz (1996) 1.38
Acitretin is converted to etretinate only during concomitant alcohol intake. Br J Dermatol (2000) 1.37
Use of ibuprofen and methylprednisolone for the prevention of pain and swelling after removal of impacted third molars. J Oral Maxillofac Surg (1995) 1.36
Pharmacokinetics of isoniazid, rifampin, and pyrazinamide in children younger than two years of age with tuberculosis: evidence for implementation of revised World Health Organization recommendations. Antimicrob Agents Chemother (2011) 1.36
Novel splice donor site mutation in the cardiac myosin-binding protein-C gene in familial hypertrophic cardiomyopathy. Characterization Of cardiac transcript and protein. J Clin Invest (1997) 1.36
Endothelium-derived relaxing factor from cultured human endothelial cells inhibits aggregation of human platelets. Thromb Res (1987) 1.35
Genetic and biochemical analysis of Staphylococcus epidermidis biofilm accumulation. Methods Enzymol (2001) 1.34
Recognition of distress and psychiatric morbidity in cancer patients: a multi-method approach. Ann Oncol (2004) 1.34
Coxsackievirus infection of the pancreas: evaluation of receptor expression, pathogenesis, and immunopathology. Virology (2000) 1.32
Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: relationship to treatment method and atherosclerotic disease. J Am Soc Nephrol (1999) 1.32
Rodents as shared indicators for zoonotic parasites of carnivores in urban environments. Parasitology (2009) 1.30
Endogenous nitric oxide synthase inhibitors are responsible for the L-arginine paradox. FEBS Lett (2000) 1.29
Short-course of oral miltefosine for treatment of visceral leishmaniasis. Clin Infect Dis (2000) 1.29
Exploring haplotype sharing methods in general and isolated populations to detect gene(s) of a complex genetic trait. Genet Epidemiol (2001) 1.26
A newly created splice donor site in exon 25 of the MyBP-C gene is responsible for inherited hypertrophic cardiomyopathy with incomplete disease penetrance. Circulation (2000) 1.26
Pulmonary hypertension correlated to pulmonary thromboxane synthesis. Adv Prostaglandin Thromboxane Res (1980) 1.25
Effect of dexamethasone on in vivo prostanoid production in the rabbit. J Clin Invest (1984) 1.24
Nitric oxide and inflammatory joint diseases. Br J Rheumatol (1998) 1.22
Metabolism of prostacyclin and 6-keto-prostaglandin F1 alpha in man. J Biol Chem (1980) 1.21
Extraction and chromatographic procedures for purification of prostaglandins, thromboxanes, prostacyclin, and their metabolites. Adv Prostaglandin Thromboxane Res (1978) 1.19
Elevated L-arginine/dimethylarginine ratio contributes to enhanced systemic NO production by dietary L-arginine in hypercholesterolemic rabbits. Biochem Biophys Res Commun (1996) 1.19
Exercise and cytokines with particular focus on muscle-derived IL-6. Exerc Immunol Rev (2001) 1.16
Two novel mutations in the GDAP1 and PRX genes in early onset Charcot-Marie-Tooth syndrome. Neuropediatrics (2008) 1.15
Association between the 5' UTR variant C178T of the serotonin receptor gene HTR3A and bipolar affective disorder. Pharmacogenetics (2001) 1.14
L-arginine infusion decreases peripheral arterial resistance and inhibits platelet aggregation in healthy subjects. Clin Sci (Lond) (1994) 1.14
Elongation of the cytoplasmic tail interferes with the fusion activity of influenza virus hemagglutinin. J Virol (1998) 1.13
4-Hydroxynonenal prevents NF-kappaB activation and tumor necrosis factor expression by inhibiting IkappaB phosphorylation and subsequent proteolysis. J Biol Chem (1999) 1.12
Deoxysugar methylation during biosynthesis of the antitumor polyketide elloramycin by Streptomyces olivaceus. Characterization of three methyltransferase genes. J Biol Chem (2001) 1.11
Pulp capping of carious exposures: treatment outcome after 5 and 10 years: a retrospective study. J Endod (2000) 1.10
Inhibitors of acyl-coenzyme A:lysolecithin acyltransferase activate the production of endothelium-derived vascular relaxing factor. J Pharmacol Exp Ther (1986) 1.10
Adaptation of the rat kidney to altered water intake and urine concentration. Pflugers Arch (1988) 1.10
Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes. J Immunol (1999) 1.08
Simplified high-performance liquid chromatographic method for 5-aminosalicylic acid in plasma and urine. J Chromatogr (1981) 1.07
Elucidation of the function of two glycosyltransferase genes (lanGT1 and lanGT4) involved in landomycin biosynthesis and generation of new oligosaccharide antibiotics. Chem Biol (2001) 1.07
Clinical pharmacokinetics of dipyrone and its metabolites. Clin Pharmacokinet (1995) 1.06
Endothelial cyclic GMP and cyclic AMP do not regulate the release of endothelium-derived relaxing factor/nitric oxide from bovine aortic endothelial cells. J Pharmacol Exp Ther (1991) 1.06
A new slow-release form of 5-aminosalicylic acid for the oral treatment of inflammatory bowel disease. Biopharmaceutic and clinical pharmacokinetic characteristics. Arzneimittelforschung (1985) 1.06
Nitric oxide inhibits the secretion of T-helper 1- and T-helper 2-associated cytokines in activated human T cells. Immunology (1997) 1.05
L-arginine induces nitric oxide-dependent vasodilation in patients with critical limb ischemia. A randomized, controlled study. Circulation (1996) 1.05
Diclofenac concentrations in synovial fluid and plasma after cutaneous application in inflammatory and degenerative joint disease. Br J Clin Pharmacol (1991) 1.05
Dietary L-arginine reduces the progression of atherosclerosis in cholesterol-fed rabbits: comparison with lovastatin. Circulation (1997) 1.04
The prostaglandin system. A role in canine baroreceptor control of renin release. Circ Res (1978) 1.03
Antidiuretic hormone increases renal prostaglandin synthesis in vivo. Am J Physiol (1978) 1.03
Prevention of postoperative swelling and pain by dexamethasone after operative removal of impacted third molar teeth. Eur J Clin Pharmacol (1993) 1.03
Ventral transdural herniation of the thoracic spinal cord: surgical treatment in four cases and review of literature. Acta Neurochir (Wien) (1999) 1.03
The carcinoid flush. Provocation by pentagastrin and inhibition by somatostatin. N Engl J Med (1978) 1.02
Microvascular decompression for the treatment of hemifacial spasm. Retrospective study of a consecutive series of 75 operated patients--electrophysiologic and anatomical surgical analysis. Stereotact Funct Neurosurg (1997) 1.01
Indomethacin increases plasma lithium. Br Med J (1979) 1.01
NF-ATp plays a prominent role in the transcriptional induction of Th2-type lymphokines. Immunol Lett (1997) 1.01
Supplementation of hypercholesterolaemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO production. Atherosclerosis (1995) 1.01
Cigarette smoking stimulates cysteinyl leukotriene production in man. Eur J Clin Invest (1997) 1.01
Processing of facial emotional expression: spatio-temporal data as assessed by scalp event-related potentials. Eur J Neurosci (2001) 1.00
Mechanisms of action of lipoxygenase and cytochrome P-450-mono-oxygenase inhibitors in blocking endothelium-dependent vasodilatation. Br J Pharmacol (1988) 1.00
Vascular release of superoxide radicals is enhanced in hypercholesterolemic rabbits. J Cardiovasc Pharmacol (1994) 1.00